Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis.
Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis.
复制标题
DOI:
10.1136/bmjhci-2020-100291
复制
发表时间:
2021-04
影响因子:
4.1
通讯作者:
Iqbal U
中科院分区:
文献类型:
--
作者:
Enricho Nkhoma D;Jenya Soko C;Joseph Banda K;Greenfield D;Li YJ;Iqbal U
To conduct systematic review and meta-analysis of interventional studies to investigate the impact of diabetes self-management education and support (DSMES) apps on adherence in patients with type 2 diabetes mellitus (T2D). PubMed, Embase, CENTRAL, Web of Science, Scopus and ProQuest were searched, in addition to references of identified articles and similar reviews. Experimental studies, reported in English, assessing DSMES app intervention’s impact on adherence and clinical outcomes of patients with T2D compared with usual care were included. Study bias was assessed using Cochrane Risk of Bias V.2.0 tool. Analysis plan involved narrative synthesis, moderator and meta-analysis. Six randomised controlled trials were included, involving 696 participants (average age 57.6 years, SD 10.59). Mobile apps were mostly used for imputing clinical data, dietary intake or physical activity, and transmitting information to the provider. At 3 months, DSMES apps proved effective in improving medication adherence (standardized mean difference (SMD)=0.393, 95% CI 0.17 to 0.61), glycated haemoglobin (HbA1c) (mean difference (MD)=−0.314, 95% CI −0.477 to –0.151) and Body Mass Index (BMI) (MD=−0.28, 95% CI −0.545 to –0.015). All pooled estimates had low heterogeneity (I2 0%). Four studies had moderate risk of bias while one each was judged to be low and high risks, respectively. DSMES apps had significant small to moderate effects on medication adherence, HbA1c and BMI of patients with T2D compared with usual care. Apps were described as reliable, easy to use and convenient, though participants were required to be phone literate. Evidence comes from feasibility trials with generally moderate risk of bias. Larger trials with longer follow-up periods using theory-based interventions are required to improve current evidence.
登录
查看更多内容
影响因子:
4
作者:
Hozo SP;Djulbegovic B;Hozo I
通讯作者:
Hozo I
DOI:
10.1331/japha.2013.12202
发表时间:
2013-03
期刊:
Journal of the American Pharmacists Association : JAPhA
影响因子:
--
作者:
Dayer L;Heldenbrand S;Anderson P;Gubbins PO;Martin BC
通讯作者:
Martin BC
影响因子:
3.9
作者:
Beck, Joni;Greenwood, Deborah A.;Wang, Jing
通讯作者:
Wang, Jing
影响因子:
16.2
作者:
Hou, Can;Carter, Ben;Mayors, Sharon
通讯作者:
Mayors, Sharon
影响因子:
4.7
作者:
Kleinman, Nora J.;Shah, Avani;Viswanathan, Vijay
通讯作者:
Viswanathan, Vijay